| Financial Year |
March 31 2023 |
| Monetary Funds |
457,718,597.54 |
| Held-for-trading Financial Assets |
81,400,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
47,261,179.26 |
| Advances to Suppliers |
33,859,777.92 |
| Other Receivables |
102,873,389.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
15,992,361.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
113,434,586.06 |
| Total Current Assets |
852,539,891.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
145,910,627.70 |
| Investment Properties |
6,738,234.50 |
| Fixed Assetes |
244,572,381.44 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
123,376,682.15 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
824,479.04 |
| Deferred Income Tax Assets |
1,003,423.17 |
| Other Non-Current Assets |
52,501.36 |
| Sub-Total of Non-Current Assets |
647,830,446.56 |
| Total Assets |
1,500,370,337.60 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
150,744,322.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,547,480.46 |
| Taxes Payable |
6,868,813.03 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,376,128.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,233,923.26 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
230,591,246.75 |
| Long-term Loans |
78,850,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,525,832.13 |
| Other Non-Current Liabilities |
882,840.65 |
| Sub-Total of Non-Current Liabilities |
100,095,387.63 |
| Total Liabilities |
330,686,634.38 |
| Paid-In Capital(Or Share Stock) |
835,339,343.00 |
| Capital Surplus |
2,766,660,544.15 |
| Surplus Reserve |
67,660,369.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,295,068,180.48 |
| Minority Stockholder's Interest |
123,680,155.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,046,003,548.04 |
| Owner's Equity（Stockholder's Equity） |
1,169,683,703.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,500,370,337.60 |
